Product Information
TRIAMCINOLONE ACET 40 MG/ML VL is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $4.8304 per ML under NDC 00143938725. Its NADAC has been published 73 times since May 14, 2025.
FDA first approved this application on Dec 9, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00143938725
Classification
Generic
Dosage Form
INJECTION, SUSPENSION
Route
INTRA-ARTICULAR; INTRAMUSCULAR
Effective Date
9/23/2026
Active Ingredients
TRIAMCINOLONE ACETONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA215254FDA Approved
12/9/2024
TE Code
AB
On Market Since
3/3/2025
Pharmacological Classes
Price Statistics
The NADAC for TRIAMCINOLONE ACET 40 MG/ML VL has been published 73 times since May 14, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.8304 per ML |
|---|---|
| All-time high | $6.0518 (Mar 11, 2026) |
| All-time low | $4.7499 (Jun 17, 2026) |
| 52-week high | $6.0518 |
| 52-week low | $4.7499 |
| Median price | $4.9016 |
| Average price | $5.1695 |
| Largest weekly change | -8.2% (May 20, 2026) |
| Weeks tracked | 73 |
| Tracking since | May 14, 2025 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Triamcinolone Acetonide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRIAMCINOLONE ACET 40 MG/ML VL?
The current National Average Drug Acquisition Cost (NADAC) for TRIAMCINOLONE ACET 40 MG/ML VL, manufactured by Hikma Pharmaceuticals USA Inc., is $4.8304 per ML (NDC 00143938725), effective Sep 30, 2026.
How has the price of TRIAMCINOLONE ACET 40 MG/ML VL changed over time?
Over the history we have for it, the NADAC for TRIAMCINOLONE ACET 40 MG/ML VL has held within roughly two percent of its current level. It has been tracked across 73 weekly CMS publications since May 14, 2025.
What are the highest and lowest recorded NADAC prices for TRIAMCINOLONE ACET 40 MG/ML VL?
Since May 14, 2025, the NADAC for TRIAMCINOLONE ACET 40 MG/ML VL has ranged from a low of $4.7499 (Jun 17, 2026) to a high of $6.0518 (Mar 11, 2026), with a median of $4.9016 per ML.
Are there cheaper alternatives to TRIAMCINOLONE ACET 40 MG/ML VL?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRIAMCINOLONE ACET 400 MG/10 ML, is $4.7820 per ML — about 1% below TRIAMCINOLONE ACET 40 MG/ML VL.
Who manufactures TRIAMCINOLONE ACET 40 MG/ML VL?
TRIAMCINOLONE ACET 40 MG/ML VL (NDC 00143938725) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.